Saccà Francesco
Università degli Studi di Napoli Federico II
H-index: 36
Europe-Italy
Top articles of Saccà Francesco
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
CHARON: An Imaging-Based Diagnostic Algorithm to Navigate Through the Sea of Hereditary Degenerative Ataxias | Alessandra Scaravilli Mario Tranfa Giuseppe Pontillo Bernard Brais Giovanna De Michele | 2024/3/4 | |
A Real-life Experience with Eculizumab and Efgartigimod in Generalized Myasthenia Gravis Patients (P4-11.009) | Francesco Sacca Nunzia Cuomo Alessio Sarnataro Mario Campanile Angela Marsili | 2024/4/14 | |
Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study (P10 … | James Howard George Li Tuan Vu Denis Korobko Marek Smilowski | 2023/4/25 | |
A Review of Brain and Pituitary Gland MRI Findings in Patients with Ataxia and Hypogonadism | Alessandra Scaravilli Mario Tranfa Giuseppe Pontillo Bernard Brais Giovanna De Michele | 2024/4 | |
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis | European Journal of Neurology | Andreas Meisel Francesco Saccà Jennifer Spillane John Vissing MG Collegium Sub‐committee | 2024/3/24 |
Long-term Effect of Ofatumumab on Serum Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis (P9-6.007) | Heinz Wiendl Jerome de Seze Amit Bar-Or Jorge Correale Anne Cross | 2023/10/1 | |
Localized Changes in Dentate Nucleus Shape and Magnetic Susceptibility in Friedreich Ataxia | Movement Disorders | Ian H Harding Muhammad Ikhsan Nur Karim Louisa P Selvadurai Louise A Corben Martin B Delatycki | 2024/4/22 |
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A | Journal of Neurology | Annalaura Torella Ivana Ricca Giulio Piluso Daniele Galatolo Giuseppe De Michele | 2023/10 |
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes | Giovanna De Michele Luigi Maione Sirio Cocozza Mario Tranfa Chiara Pane | 2023/3/30 | |
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) | Multiple Sclerosis and Related Disorders | Teresa Costabile Elisabetta Signoriello Francesca Lauro Manuela Altieri Antonio Rosario Ziello | 2023/6/1 |
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients | The Cerebellum | Chiara Pane Assunta Trinchillo Andrea Salzano Angela Marsili Giorgia Puorro | 2023/10 |
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence | Journal of Clinical Medicine | Elisabetta Signoriello Giacomo Lus Francesco Saccà Marco Puthenparampil Cinzia Coppola | 2023/2/22 |
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy | Francesco Saccà Emmanuelle Salort‐Campana Saiju Jacob Elena Cortés‐Vicente Christiane Schneider‐Gold | 2023/12/20 | |
Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis | Presented at the CMSC Annual Meeting | Jeffrey A Cohen Stephen L Hauser Anne H Cross Kevin Winthrop Heinz Wiendl | 2023/5/31 |
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) | Frontiers in Neuroscience | Chiara Pane Alberto Maria Marra Ludovica Aliberti Mario Campanile Federica Coscetta | 2023/9/7 |
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG | BMJ open | Sarah Dewilde Glenn Philips Sandra Paci Jon Beauchamp Silvia Chiroli | 2023/1/1 |
Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis regardless of prior treatment failures | Journal of the Neurological Sciences | Zaeem Siddiqi Csilla Rozsa Francesco Saccá Jan L De Bleecker Jan Verschuuren | 2023/12/1 |
Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG) | Bmj Open | Sonia Berrih-Aknin Jacqueline Palace Andreas Meisel Kristl G Claeys Srikanth Muppidi | 2023/5/1 |
P. 044 Efficacy, safety, and tolerability of efgartigimod in AChR-Ab–patients with Generalized Myasthenia Gravis: interim analysis of ADAPT/ADAPT+ | Canadian Journal of Neurological Sciences | V Bril T Vu C Karam S Peric JL De Bleecker | 2023/6 |
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective | Giacomo Lus Marco André Bassano Vincenzo Brescia Morra Simona Bonavita Antonio Gallo | 2023/1 |
Co-Authors
